Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

TTyra Biosciences, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
T

Tyra Biosciences, Inc.

$25.57Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
    • Revenue & profit
    • Revenue by segment
    • Launches
    • Revenue concentration
    • Margins
    • Contracted revenue
    • Off-balance-sheet commitments
    • Cash flow
    • Cash & debt
    • Earnings per share
    • P/E ratio
    • Share count & dilution
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financial graphs

Metrics

Revenue & profit
Revenue by segment
Margins
Contracted revenue
Cash flow
Cash & debt
Earnings per share
Share count & dilution

Metrics

See the amounts the company has committed to pay that its balance sheet does not record yet: leases it has signed that have not started, unconditional purchase and other contractual commitments, and the most it could have to pay under guarantees and credit backstops. Amounts are as the filing reports them at each balance-sheet date.Formula: Commitments = leases not yet commenced + purchase & other commitments + maximum guarantee exposure
202220202021202220242025202601M2M3M4M5M
      Latest period 2022. Leases not yet commenced 5.5M.
      Leases not yet commencedPurchase & other commitmentsGuarantees & contingent commitments
      Compare cash generated by the business, spending on long-lived assets, and what remains afterward.Formula: Free cash flow = operating cash flow − capital expenditures
      $
      2025202020212022202320242025-80M-60M-40M-20M0
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        Latest period 2025. Operating cash flow -95.1M. Capex -141K. Free cash flow -95.3M.
        Operating cash flowCapexFree cash flow
        Compare the company’s cash cushion with its borrowings. Negative net cash means debt is greater than cash.Formula: Net cash = cash − debt
        202620202021202220232024202520260100M200M300M
            Latest period 2026. Cash 73.8M. Debt 0.
            CashDebtNet cash
            Profit for each share over the trailing 12 months, adjusted for stock splits.Formula: Earnings available to common shareholders ÷ weighted-average shares
            $/shareUsing split history cached 2026-09-23; assuming no new splits
            2025202020212022202320242025-6.00-4.00-2.000.00
              • Earnings period 2020-01-01 to 2020-12-31. Shares as of 2020-12-31: 1,829,377 source shares.
              • Earnings period 2021-01-01 to 2021-12-31. Shares as of 2021-12-31: 41,441,135 source shares.
              • Earnings period 2022-01-01 to 2022-12-31. Shares as of 2022-12-31: 42,353,550 source shares.
              • Earnings period 2023-01-01 to 2023-12-31. Shares as of 2023-12-31: 43,024,634 source shares.
              • Earnings period 2024-01-01 to 2024-12-31. Shares as of 2024-12-31: 50,749,945 source shares.
              • Earnings period 2025-01-01 to 2025-12-31. Shares as of 2025-12-31: 53,706,357 source shares.
              Latest period FY 2025. EPS (TTM) -2.23.
              EPS (TTM)
              How much investors pay for each dollar of the company’s yearly earnings. It is not useful when the company has no profit.Formula: Share price ÷ trailing 12-month EPS
              Using split history cached 2026-09-23; assuming no new splits
              historical price missing or staleMissing2025202020212022202320242025-20x-15x-10x-5x0x
              • FY 2020: historical price missing or stale
              • Earnings period 2020-01-01 to 2020-12-31. Shares as of 2020-12-31: 1,829,377 source shares.
              • Earnings period 2021-01-01 to 2021-12-31. Shares as of 2021-12-31: 41,441,135 source shares. Weekly price on 2021-12-31.
              • Earnings period 2022-01-01 to 2022-12-31. Shares as of 2022-12-31: 42,353,550 source shares. Nearby weekly price on 2022-12-30.
              • Earnings period 2023-01-01 to 2023-12-31. Shares as of 2023-12-31: 43,024,634 source shares. Nearby weekly price on 2023-12-29.
              • Earnings period 2024-01-01 to 2024-12-31. Shares as of 2024-12-31: 50,749,945 source shares. Nearby weekly price on 2025-01-03.
              • Earnings period 2025-01-01 to 2025-12-31. Shares as of 2025-12-31: 53,706,357 source shares. Nearby weekly price on 2026-01-02.
              Latest period FY 2025. P/E ratio -12x.
              P/E ratio
              See how the number of shares changes over time. More shares can mean each existing share owns a smaller slice of the company.Formula: Outstanding shares = issued shares − treasury shares Share-count growth = (current shares ÷ previous shares − 1) × 100%
              Stock split history may be out of date.
              20262020202120222023202420252026020M40M60M
                  Latest period 2026. Shares outstanding 59.7M. Class detail unavailable 59.7M.
                  Class detail unavailable